F4E-20445-46184
2 vaccinations
2 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 660 / KS
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-05
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-03-10
- 2021-03-17
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-23
- 2021-04-28
- 2021-05-05
- 2021-06-26
-
2021-09-22
Survey response — 6 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Abnormally heavy periodsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-22
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-24
-
2022-03-26
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Surgery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Miscarriage · Healthcare visit (other): SurgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-03-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-03-28
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-22 | Successful | Does not wish to fill out VAERS report |
| 2022-03-26 | Successful 2022-03-28 |
Does not wish to fill out VAERS report |
Free text
Release 9 — 6 months, dose 2
Symptoms: Abnormally heavy periods
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release